PET-CT

PET-CT is an innovative method for diagnosing cancer, which allows you to identify a benign or malignant tumor at an early stage, to clarify its size and determine the area of growth. The procedure combines the principles of positron emission and computed tomography. Such a diagnosis in most cases is much more effective than ultrasound, x-ray or MRI.

PET-CT with 18F-fluorodeoxyglucose

Various radiopharmaceuticals are used to detect malignant tumor cells in the body. The most effective of them today is considered 18F-fluorodeoxyglucose. It is prepared immediately before the diagnostic procedure, taking into account the characteristics of the patient's body.

Benefits of using PET-CT in the diagnosis of cancer

An accurate assessment of the extent of tumor tissue damage is very important for the subsequent development of a treatment regimen. PET-CT is also prescribed for patients who have undergone chemotherapy or radiotherapy. With its help, you can monitor the effectiveness of the therapy, see how the tumor has changed over time, whether new foci or relapses have appeared.

Among the other benefits of using PET-CT:

  • identification of cancerous tumors at a stage when the symptoms of the disease have not even begun to manifest;
  • the procedure is performed on an outpatient basis, without the need for surgical intervention;
  • the diagnosis is safe for health, there is no pain;
  • It is possible to obtain comprehensive information about the general condition of the body and the spread of the tumor.

The essence of PET-CT diagnostics is to determine the metabolic rate of cells, which allows you to visualize even the smallest tumors, with a diameter of only 4-5 mm.

Indications for appointment

PET-CT is performed to:

  • identifying the original foci of the tumor and possible metastases in other parts of the body;
  • assessment of the results of ongoing or already completed therapy;
  • planning a strategy for further treatment;
  • determining the general stage of tumor growth;
  • differentiation of neoplasms.

Readings in detail

In our clinic, we assign PET-CT to patients with a previously diagnosed or suspected malignancy of the skeleton, pancreatic cancer, melanoma. Such a diagnosis is indispensable for cancer of the thyroid and pancreas, lungs, ovaries, gastrointestinal tract, soft tissue sarcoma, etc.

Important! The examination itself takes no more than an hour. But, it may take additional time to prepare the patient for the procedure, paperwork, rest after diagnosis, etc.

Diagnostic preparation

In order for the doctor to obtain comprehensive and reliable data during PET-CT, preliminary preparation for the procedure is necessary:

  • two days before the examination should abandon alcohol and carbohydrate foods, including baking, sweets, sweet water;
  • do not eat for six hours before coming to the medical center;
  • drink plenty of fluids before testing.

If possible, bring with you the data of past examinations and the results of the diagnostic procedures available on your outpatient card.

Contraindications

PET-CT, like any other medical procedure, has a number of contraindications:

  • pregnancy or lactation;
  • the presence of neuropsychiatric diseases;
  • period of exacerbation of inflammation in the body;
  • diabetes;
  • chronic renal or liver failure.

Some of the contraindications are considered relative, others are absolute. The decision on the feasibility of a PET-CT diagnosis in one case or another is made by the attending physician.

During the preliminary appointment for the PET-CT procedure, our administrators will select the convenient date and time for the examination, tell you in detail about all the nuances of preparing for the procedure and answer any related questions.

Service record



Specialists

All specialists
Merkulov
Igor Alexandrovich

Deputy chief physician for oncology, oncologist

Doctor of Sciences, PhD


Academician, professor, Doctor of Sciences, PhD

Petrov
Dmitry Yurevich

Deputy chief physician for oncology, surgeon

PhD, Docent

Ershova
Ksenia Igorevna

Head of department, oncologist

PhD

Rasner
Pavel Ilyich

Consultant in urology, urologist

Doctor of Sciences, PhD, professor

Malygin
Sergey Evgenyevich

Oncologist-mammologist, surgeon

Pshikhachev
Ahmed Mukhamedovich

Urologist, Oncologist

Doctor of Sciences, PhD

Shevchuk
Alexei Sergeyevich

Oncogynecology consultant, obstetrician-gynecologist

PhD

Chichkanova
Tatyana Vladimirovna

Oncologist-mammologist, radiologist

Katz
Ksenia Vladimirovna

Dermatovenerologist, oncologist

Rakova
Elena Sergeevna

Oncologist, chemotherapist

Udin
Oleg Ivanovich

Deputy chief physician for surgery, surgeon

PhD

Kogonia
Lali Mikhailovna

Chemotherapist

Doctor of Sciences, PhD

Ushenina
Maria Valerievna

Oncologist-chemotherapist

PhD

Stepura
Yulia Evgenievna

Head of the department of antitumor drug therapy, oncologist, chemotherapist

Volkova
Daria Mikhailovna

Head of the radiation therapy department

Gomov
Mikhail Alexandrovich

Consultant in oncogynecology, obstetrician-gynecologist

Grishin
Igor Igorevich

Obstetrician-gynecologist

Doctor of Sciences, PhD, professor

Achba
Maya Otarovna

Radiologist, ultrasound diagnostician, oncologist-mammologist